Alwyn Capital

Alwyn Capital is an impact-driven venture capital firm based in New York that invests at the earliest stages in biotechnology that reduces dependence on animals. It sees this as a strategic imperative for tackling both climate and human health challenges. The firm backs innovations in three areas: food ingredients from plants, microbes, and cells, non-animal materials for fashion and other industries, and human organ-on-chip technology as an alternative to animal testing. Fund One portfolio companies include Sunflower TX, a continuous biomanufacturing company, uFraction8, a next-generation bioseparation company, New School Foods, Atlantic Fish Co, and Aux Labs, which is brewing the future of dairy. Other backed companies include UPSIDE Foods, Emulate, Geltor, and Avant Meats. Alwyn looks for scalable, sustainable innovations that drive efficiency, reduce environmental impact, and future-proof industries. It accepts investment applications through its website.